These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 25342235)

  • 21. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction.
    Lee M; Aronne LJ
    Am J Cardiol; 2007 Feb; 99(4A):68B-79B. PubMed ID: 17307059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of diabetes development in those with the metabolic syndrome.
    Tupper T; Gopalakrishnan G
    Med Clin North Am; 2007 Nov; 91(6):1091-105, viii-ix. PubMed ID: 17964911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel therapies for cardiometabolic risk reduction and implications for clinical practice.
    Watson KE
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S37-42. PubMed ID: 17934393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic options for the prevention of type 2 diabetes mellitus in the metabolic syndrome.
    Lukacova-Zib I; Gopalakrishnan G
    Mt Sinai J Med; 2010; 77(5):524-32. PubMed ID: 20960554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Insulin resistance, metabolic syndrome and cardiovascular diseases].
    Zeman M; Zák A; Vecka M; Tvrzická E
    Cas Lek Cesk; 2005; 144 Suppl 1():19-20, 22-6. PubMed ID: 15981981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The progression of cardiovascular risk to cardiovascular disease.
    Rosin BL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular implications of antihyperglycemic therapies for type 2 diabetes.
    Ovalle F
    Clin Ther; 2011 Apr; 33(4):393-407. PubMed ID: 21635987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention and treatment of the metabolic syndrome.
    Daskalopoulou SS; Mikhailidis DP; Elisaf M
    Angiology; 2004; 55(6):589-612. PubMed ID: 15547646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of the metabolic syndrome.
    Grant RW; Meigs JB
    Panminerva Med; 2005 Dec; 47(4):219-28. PubMed ID: 16489321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Metabolic syndrome. Part III: its prevention and therapeutic management].
    Pacholczyk M; Ferenc T; Kowalski J
    Postepy Hig Med Dosw (Online); 2008 Oct; 62():559-70. PubMed ID: 18936731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal treatments for the metabolic syndrome.
    Giugliano D; Esposito K
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):e30. PubMed ID: 16556857
    [No Abstract]   [Full Text] [Related]  

  • 32. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular disease under the influence of excess visceral fat.
    Després JP
    Crit Pathw Cardiol; 2007 Jun; 6(2):51-9. PubMed ID: 17667865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic options for treatment of cardiometabolic risk].
    Stokić E; Tomić-Naglić D; Derić M; Jorga J
    Med Pregl; 2009; 62 Suppl 3():54-8. PubMed ID: 19702117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic syndrome: treatment of hypertensive patients.
    Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
    Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular risk: prevention and treatment of the metabolic syndrome.
    Tuomilehto J
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl 2():S28-35. PubMed ID: 15953504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of the insulin resistance syndrome.
    Meigs JB
    Curr Diab Rep; 2003 Feb; 3(1):73-9. PubMed ID: 12643149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.
    Grams J; Garvey WT
    Curr Obes Rep; 2015 Jun; 4(2):287-302. PubMed ID: 26627223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome: are we at risk?
    Paudel B
    Nepal Med Coll J; 2007 Sep; 9(3):204-11. PubMed ID: 18092442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.